Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands
Abstract
Authors
N Germain S Aballéa M Romano NA Hawken M Toumi